MML Investors Services
ABEO icon

MML Investors Services’s Abeona Therapeutics ABEO Stock Holding History

MML Investors Services’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$2K – 2071
2022
Q2 		$2K Hold
400
– – ﹤0.01% 2026
2022
Q1 		$3K Hold
400
– – ﹤0.01% 2053
2021
Q4 		$3K Hold
400
– – ﹤0.01% 2012
2021
Q3 		$11K Hold
400
– – ﹤0.01% 1945
2021
Q2 		$16K Buy
+400
New +$16.3K ﹤0.01% 1891

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MML Investors Services's ABEO Position: Q3 2022 in Review

MML Investors Services sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 400 shares — an estimated $2K sold.

MML Investors Services first reported a position in ABEO in Q2 2021 and held it in 5 quarters. The position peaked at $16K in Q2 2021. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • MML Investors Services reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • MML Investors Services sold 400 Abeona Therapeutics shares in Q3 2022, an estimated $2K.
  • MML Investors Services first reported a position in Abeona Therapeutics in Q2 2021 and held it in 5 quarters.
  • MML Investors Services's Abeona Therapeutics position peaked at $16K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on MML Investors Services's 13F filing for Q3 2022, filed 14 Nov 2022.